DK0500921T3 - Na-K-ATPase-inhiberende natriuretiske substanser - Google Patents

Na-K-ATPase-inhiberende natriuretiske substanser

Info

Publication number
DK0500921T3
DK0500921T3 DK91918625T DK91918625T DK0500921T3 DK 0500921 T3 DK0500921 T3 DK 0500921T3 DK 91918625 T DK91918625 T DK 91918625T DK 91918625 T DK91918625 T DK 91918625T DK 0500921 T3 DK0500921 T3 DK 0500921T3
Authority
DK
Denmark
Prior art keywords
natriuretic
compounds
substances
atpase inhibiting
methods
Prior art date
Application number
DK91918625T
Other languages
Danish (da)
English (en)
Inventor
Harvey C Gonick
Elmar Weiler
Farhad Khalil-Manesh
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of DK0500921T3 publication Critical patent/DK0500921T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K4/00—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C07K4/12—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK91918625T 1990-09-11 1991-09-11 Na-K-ATPase-inhiberende natriuretiske substanser DK0500921T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58158290A 1990-09-11 1990-09-11
PCT/US1991/006554 WO1992004910A1 (fr) 1990-09-11 1991-09-11 Substances natriuretiques inhibant la na-k-atpase

Publications (1)

Publication Number Publication Date
DK0500921T3 true DK0500921T3 (da) 1999-11-29

Family

ID=24325750

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91918625T DK0500921T3 (da) 1990-09-11 1991-09-11 Na-K-ATPase-inhiberende natriuretiske substanser

Country Status (9)

Country Link
US (1) US5667811A (fr)
EP (1) EP0500921B1 (fr)
AT (1) ATE180167T1 (fr)
AU (1) AU650490B2 (fr)
CA (1) CA2068412A1 (fr)
DE (1) DE69131248T2 (fr)
DK (1) DK0500921T3 (fr)
OA (1) OA09700A (fr)
WO (1) WO1992004910A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000044931A2 (fr) * 1999-01-28 2000-08-03 Bion, Inc. TESTS DE CRIBLAGE A DEBIT ELEVE POUR DES MODULATEURS DE L'ATPase Na?+-K+¿

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4321120A (en) * 1980-03-19 1982-03-23 Nardi Ronald V Process for detecting proteins specific to hypertension in mammals
US4665019A (en) * 1983-08-31 1987-05-12 University Of Maryland Method for measuring the plasma levels of an inhibitor of (Na+ +K.sup.+
JPS6060557A (ja) * 1983-09-13 1985-04-08 Eisai Co Ltd Ｐｉｖｋａ−２の測定方法および試薬
US4943533A (en) * 1984-03-01 1990-07-24 The Regents Of The University Of California Hybrid cell lines that produce monoclonal antibodies to epidermal growth factor receptor
DE3445933A1 (de) * 1984-12-17 1986-06-19 Röhm GmbH, 6100 Darmstadt Arzneimittel mit diuretischer wirksamkeit
GB8516081D0 (en) * 1985-06-25 1985-07-31 Ciba Geigy Ag Assay & purification of amyloid components
US4780314A (en) * 1985-10-30 1988-10-25 Brigham And Women's Hospital Isolation and purification of a digitalis-like factor
US4940670A (en) * 1986-01-24 1990-07-10 Rhodes Buck A Method for compounding and testing patient specific monoclonal antibodies and monoclonal antibody fragments for in vivo use
FR2597483B1 (fr) * 1986-04-18 1993-09-10 Flork Michel Nouveaux peptides diuretiques et natriuretiques.
US4746652A (en) * 1986-11-18 1988-05-24 Wake Forest University Method of inducing diuresis with lysophospholipids
US4940782A (en) * 1987-06-08 1990-07-10 G. D. Searle & Co. Monoclonal antibodies against IgE-associated determinants, hybrid cell lines producing these antibodies, and use therefore

Also Published As

Publication number Publication date
CA2068412A1 (fr) 1992-03-12
ATE180167T1 (de) 1999-06-15
AU8761791A (en) 1992-04-15
WO1992004910A1 (fr) 1992-04-02
AU650490B2 (en) 1994-06-23
OA09700A (en) 1993-08-30
DE69131248D1 (de) 1999-06-24
DE69131248T2 (de) 1999-12-16
US5667811A (en) 1997-09-16
EP0500921B1 (fr) 1999-05-19
EP0500921A4 (en) 1993-05-26
EP0500921A1 (fr) 1992-09-02

Similar Documents

Publication Publication Date Title
ATE295176T1 (de) Verfahren zur unterstützung der differentialdiagnostik und behandlung von autistischen syndromen
ATE192339T1 (de) Verwendung von fulleren-derivaten in diagnostischen und/oder therapeutischen mitteln
ATE232396T1 (de) Oxydiertes thymosin beta 4
CY1112197T1 (el) Πεπτιδια που σχετιζονται με το συν-πολυμερες (copolymer) 1 για χρηση σαν παραγοντες σημανσης μοριακου βαρους και για θεραπευτικη χρηση
BE866698A (fr) Poche pour recueillir, conserver et administrer notamment filtrer du sang, des constituants sanguins et des fluides intraveineux et similaires
EE9900481A (et) Väikesed molekulid, mida kasutatakse põletikuliste haiguste raviks
MX9703621A (es) Nuevos derivados aminoacidos con actividad mejorada para la resistencia a drogas multiples.
NO20014415L (no) Medisinske preparater til behandling av <alfa>-galaktosidase- A-defisiens
NZ210275A (en) Modified hirudin and its antithrombin properties
DK524187A (da) Aminosyrechelaterede midler til udlevering til specifikke biologiske vaevssteder
DK0552296T3 (da) Monoklonale antistoffer fra mus
FI972308A (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
DE69719754D1 (de) Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung
DK0845998T3 (da) Lægemidler til immunbehandling indeholdende antistoffer, der specifikt genkender MHCII-antigenet hos en patient, der skal behandles
DK0489877T3 (da) Antiatherosklerotiske og antithrombotiske 2-amino-6-phenyl-4H-pyran-4-oner
ATE60329T1 (de) Cumarinderivate, diese enthaltende pharmazeutische zubereitungen und ihre verwendung bei der behandlung von krebs.
ATE81467T1 (de) Immunosuppression bei der auf immunotoxin basierten behandlung von menschen.
BG93298A (bg) Имуностимулиращи 6-арил-5,6-дихидроимидазо(2,1-в)тиазолови производни
DK0500921T3 (da) Na-K-ATPase-inhiberende natriuretiske substanser
ATE58478T1 (de) Zubereitungen und verfahren zum schutz von tlymphozyten gegen das krankheitsagens von lymphadenopathie und vom erworbenen immundepressionsyndrom.
ATE40116T1 (de) 1-acyl-3-pyridylmethylguanidine und deren verwendung als antihypertensiva.
ATE132877T1 (de) Emulgatorfreie emulsionspolymere in pharmazeutischen zubereitungen mit verzögerter wirkstofffreigabe und ihre herstellung
IT8220995V0 (it) Confezione per la presentazione di indumenti in genere, in particolare di biancheria intima, o di altri prodotti, per uso personale.
ATE306269T1 (de) Behandlung der exzessiven aggressivität mit olanzapine
Wrigley et al. Normal cerebral function with bilateral carotid occlusion.